Novartis Investigative Site

Hyōgo 670-8520

0 studies enrolling now · 2 studies all time

What they study most

Endometrial Cancer, Lymphoma, Follicular

Studies at this site

• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early
• BEZ235 Trial in Patients With Advanced Endometrial Carcinoma — Withdrawn before enrolling